does semaglutide interact with adderall Wegovy and Adderall: Interactions, Safety and Clinical Guidance Wegovy and Adderall Interactions: Does

SELECT Trial: The Evidence for CV Coverage The SELECT trial (published in NEJM, November 2023) demonstrated that Wegovy reduces cardiovascular events: [27] 20% reduction in major adverse cardiovascular events (MACE) Includes heart attacks, strokes, and cardiovascular death 17,604 participants followed for ~3.3 years All participants had established cardiovascular disease plus obesity/overweight Typical Plan Coverage Criteria for CV Indication Medicare plans that cover Wegovy for cardiovascular risk reduction typically require: Clinical Criteria Established cardiovascular disease (prior heart attack, stroke, or peripheral artery disease) BMI (body mass index) 27 kg/m No Type 2 diabetes (or T2D not adequately controlled) Concurrent lifestyle modifications (diet and exercise) Required Documentation Cardiology records documenting established CVD Current BMI (height and weight within last 30 days) Letter of Medical Necessity from cardiologist or primary care provider Documentation of lifestyle modification attempts ICD-10 Codes for CV vs

Some people tolerate higher doses immediately with minimal discomfort, while others feel every incremental increase in dose

Research from the SURMOUNT trials shows that most people on tirzepatide reach a plateau between weeks 24 and 36, depending on their starting BMI

Noninvasive treatments, such as auricular nerve stimulation and experimental thoracic magnetic neurostimulation, show promising results as adjunctive therapies in restoring normal motility and alleviating symptoms

Personalized Treatment at PlexusDx: Genetic Testing and Supplement Planning PlexusDx offers the Precision Peptide Genetic Testa peptide-pathway genetic assessment that identifies your unique genetic variants affecting GLP-1 and GLP-2 receptor sensitivity, appetite regulation genes like FTO and MC4R, and other metabolic markers